Gender-specific associations between polymorphisms of the circadian gene RORA and cutaneous melanoma susceptibility

[1]  A. Carè,et al.  Sex and Gender Disparities in Melanoma , 2020, Cancers.

[2]  S. Mocellin,et al.  Germline polymorphisms of circadian genes and gastric cancer predisposition , 2020, Cancer communications.

[3]  A. Castrucci,et al.  The molecular clock in the skin, its functionality, and how it is disrupted in cutaneous melanoma: a new pharmacological target? , 2019, Cellular and Molecular Life Sciences.

[4]  S. Mocellin,et al.  E2F1 germline copy number variations and melanoma susceptibility , 2019, Journal of Translational Medicine.

[5]  M. Fargnoli,et al.  Familial Melanoma: Diagnostic and Management Implications , 2019, Dermatology practical & conceptual.

[6]  S. Mocellin,et al.  Associations of clock genes polymorphisms with soft tissue sarcoma susceptibility and prognosis , 2018, Journal of Translational Medicine.

[7]  Jeffrey E. Lee,et al.  Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival , 2018, International journal of cancer.

[8]  A. Castrucci,et al.  Non-Metastatic Cutaneous Melanoma Induces Chronodisruption in Central and Peripheral Circadian Clocks , 2018, International journal of molecular sciences.

[9]  G. Damante,et al.  A polymorphic GGC repeat in the NPAS2 gene and its association with melanoma , 2017, Experimental biology and medicine.

[10]  S. Mocellin,et al.  Germline variation of circadian pathway genes and prognosis of gastric cancer patients , 2017, Gut.

[11]  C. Helfrich-Förster,et al.  Genetic variation of clock genes and cancer risk: a field synopsis and meta-analysis , 2017, Oncotarget.

[12]  M. Mottolese,et al.  Gender effects of single nucleotide polymorphisms and miRNAs targeting clock-genes in metastatic colorectal cancer patients (mCRC) , 2016, Scientific Reports.

[13]  A. Jetten,et al.  RORα and RORγ expression inversely correlates with human melanoma progression , 2016, Oncotarget.

[14]  J. Copland,et al.  Steroid hormone influence on melanomagenesis , 2015, Molecular and Cellular Endocrinology.

[15]  Dong Liang,et al.  Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC) , 2015, Journal of genetics and genome research.

[16]  A. Stratigos,et al.  Genetic epidemiology of malignant melanoma susceptibility. , 2015, Melanoma management.

[17]  Z. Dai,et al.  Current evidence on the relationship between two common polymorphisms in NPAS2 gene and cancer risk. , 2015, International journal of clinical and experimental medicine.

[18]  Mingfeng Zhang,et al.  Teenage acne and cancer risk in US women: A prospective cohort study , 2015, Cancer.

[19]  J. Ford,et al.  Incidence and outcomes of pregnancy‐associated melanoma in New South Wales 1994–2008 , 2015, The Australian & New Zealand journal of obstetrics & gynaecology.

[20]  Yibing Chen,et al.  Functional polymorphisms of circadian negative feedback regulation genes are associated with clinical outcome in hepatocellular carcinoma patients receiving radical resection , 2014, Medical Oncology.

[21]  P. Guénel,et al.  Breast cancer risk, nightwork, and circadian clock gene polymorphisms. , 2014, Endocrine-related cancer.

[22]  J. Xing,et al.  Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients , 2014, Cancer science.

[23]  A. Qureshi,et al.  Personal history of prostate cancer and increased risk of incident melanoma in the United States. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  A. Vaiopoulou,et al.  Association of the clock genes polymorphisms with colorectal cancer susceptibility , 2013, Journal of surgical oncology.

[25]  A. Brooks-Wilson,et al.  Shift work, circadian gene variants and risk of breast cancer. , 2013, Cancer epidemiology.

[26]  Helge Kjuus,et al.  Analysis of polymorphisms in the circadian-related genes and breast cancer risk in Norwegian nurses working night shifts , 2013, Breast Cancer Research.

[27]  Z. Lengyel,et al.  Altered expression patterns of clock gene mRNAs and clock proteins in human skin tumors , 2013, Tumor Biology.

[28]  P. Kraft,et al.  Circadian genes and breast cancer susceptibility in rotating shift workers , 2012, International journal of cancer.

[29]  R. Stevens,et al.  Genetic and epigenetic associations of circadian gene TIMELESS and breast cancer risk , 2012, Molecular carcinogenesis.

[30]  J. Xing,et al.  A functional polymorphism in PER3 gene is associated with prognosis in hepatocellular carcinoma , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[31]  J. Xing,et al.  Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer , 2012, Cancer.

[32]  Wei Zhang,et al.  The role of polymorphisms in circadian pathway genes in breast tumorigenesis , 2011, Breast Cancer Research and Treatment.

[33]  Anbupalam Thalamuthu,et al.  A combined analysis of genome-wide association studies in breast cancer , 2011, Breast Cancer Research and Treatment.

[34]  Minyi Xu,et al.  Sex Hormones in Autism: Androgens and Estrogens Differentially and Reciprocally Regulate RORA, a Novel Candidate Gene for Autism , 2011, PloS one.

[35]  Herbert Yu,et al.  The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer , 2010, Breast Cancer Research and Treatment.

[36]  Wei Zheng,et al.  A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33 , 2010, Nature Genetics.

[37]  Theodore R Holford,et al.  Molecular and Cellular Pathobiology Transcriptional Profiling Analyses , 2022 .

[38]  J. Stanford,et al.  Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. , 2009, Cancer research.

[39]  H. Okamura,et al.  Molecular clocks in mouse skin. , 2009, The Journal of investigative dermatology.

[40]  A. Jetten.  Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism , 2009, Nuclear receptor signaling.

[41]  T. Burris.  Nuclear hormone receptors for heme: REV-ERBalpha and REV-ERBbeta are ligand-regulated components of the mammalian clock. , 2008, Molecular endocrinology.

[42]  T. Holford,et al.  Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk , 2008, Breast Cancer Research and Treatment.

[43]  Kurt Straif,et al.  Carcinogenicity of shift-work, painting, and fire-fighting. , 2007, The Lancet. Oncology.

[44]  K. Yu,et al.  Variants in circadian genes and prostate cancer risk: a population-based study in China , 2007, Prostate Cancer and Prostatic Diseases.

[45]  M. Kasuga,et al.  Favorable Genetic Polymorphisms Predictive of Clinical Outcome of Chemoradiotherapy for Stage II/III Esophageal Squamous Cell Carcinoma in Japanese , 2007, American journal of clinical oncology.

[46]  P. Boyle,et al.  Ala394Thr polymorphism in the clock gene NPAS2: A circadian modifier for the risk of non‐Hodgkin's lymphoma , 2007, International journal of cancer.

[47]  F. Rastinejad.  Faculty Opinions recommendation of Crystal structure of the human RORalpha Ligand binding domain in complex with cholesterol sulfate at 2.2 A. , 2006 .

[48]  F. Dominici,et al.  Cancer incidence among female flight attendants: a meta-analysis of published data. , 2006, Journal of women's health.

[49]  C. Canova,et al.  Cancer incidence among male military and civil pilots and flight attendants: an analysis on published data , 2005, Toxicology and industrial health.

[50]  M. Kasuga,et al.  Circadian Variability of Pharmacokinetics of 5-Fluorouracil and CLOCK T3111C Genetic Polymorphism in Patients With Esophageal Carcinoma , 2005, Therapeutic drug monitoring.

[51]  T. Takumi,et al.  The orphan nuclear receptor RORα regulates circadian transcription of the mammalian core-clock Bmal1 , 2005, Nature Structural &Molecular Biology.

[52]  B. Fournier,et al.  Crystal Structure of the Human RORα Ligand Binding Domain in Complex with Cholesterol Sulfate at 2.2 Å* , 2004, Journal of Biological Chemistry.

[53]  M. Geiser,et al.  X-Ray Structure of the hRORα LBD at 1.63 Å , 2002 .

[54]  Sumio Sugano,et al.  A transcription factor response element for gene expression during circadian night , 2002, Nature.

[55]  S. Hill,et al.  Transcriptional repression of RORα activity in human breast cancer cells by melatonin , 2001, Molecular and Cellular Endocrinology.

[56]  M. Mason,et al.  Systemic treatments for metastatic cutaneous melanoma. , 2000, The Cochrane database of systematic reviews.

[57]  F. Speizer,et al.  Oral contraceptive use and risk of melanoma in premenopausal women , 1999, British Journal of Cancer.

[58]  R. Evans,et al.  Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. , 1994, Genes & development.

[59]  M. Becker‐André,et al.  Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences. , 1993, Biochemical and biophysical research communications.

[60]  William D. Dupont,et al.  Power and sample size calculations. A review and computer program. , 1990, Controlled clinical trials.

[61]  J. Reid,et al.  DOI : will be inserted by hand later ) X-ray emission from expanding cocoons , 2008 .

[62]  C. Garbe,et al.  Epidemiology of Skin Cancer: Update 2019. , 2020, Advances in experimental medicine and biology.

[63]  Jennifer R. Rider,et al.  Circadian clock genes and risk of fatal prostate cancer , 2014, Cancer Causes & Control.

[64]  Sobia Rana,et al.  Lack of association of the NPAS2 gene Ala394Thr polymorphism (rs2305160:G>A) with risk of chronic lymphocytic leukemia. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[65]  J. Olson,et al.  Circadian pathway genes in relation to glioma risk and outcome , 2013, Cancer Causes & Control.

[66]  Tom R. Gaunt,et al.  American Journal of Epidemiology Practice of Epidemiology Hardy-weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies , 2022 .

[67]  R. Herings,et al.  Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[68]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[69]  M. Geiser,et al.  X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha. , 2002, Structure.

[70]  W. Dupont,et al.  Power and sample size calculations. A review and computer program. , 1990, Controlled clinical trials.